Pharmacologic therapy in COPD aimed to achieve symptomatic relief, improve quality of life, and prevent the disease progression measured by lung function decline or aggravation of emphysema. Pharmacologic agents which can effectively stop disease progression are not currently available so far, although ...
The goals of pharmacologic management of COPD are to enhance smoking cessation, alleviate dyspnea by promoting bronchodilatation, treating exacerbations, and preserving lung function. The step approach to the use of bronchodilators based upon the degree of dyspnea is reviewed with particular attention to...
The American Thoracic Society (ATS) just released itsclinical practice guideline on pharmacologic management of COPDonline in the form ofa physician summary. The recommendations on using inhalers for dyspnea and respiratory-related quality of life come froma systematic review and meta-analysis, also p...
This chapter provides discussion of 1) the currently recommended pulmonary pharmacological treatment, 2) the interaction between COPD and cardiovascular disease, and the implications for pharmacological management, 3) an overview of the management of osteoporosis in COPD, 4) the interaction between COPD ...
Exercise and pharmacologic stress testing is an important electrophysiologic testing modality in the evaluation and management of patients who have known or suspected coronary heart disease and the therapeutic effects of cardiac drugs. Exercise tolerance test or stress test is noninvasive. Patients are ...
Taking pharmacologic management of COPD into the future: combination therapies strike a critical balance in symptom reliefWinfred MandaStephen I. Rennard
Introduction: This study aims to compare two vasoconstrictors: - norepinephrine and phenylephrine - in the management of dopamine- resistant septic shock... G Jain,DK Singh - 《Indian Journal of Critical Care Medicine》 被引量: 20发表: 2010年 加载更多来源...
What is the best pharmacologic management of insomnia in patients with COPD? Evidence-Based Answer: Triazolam and zolpidem increase total sleep time (TST) by 23 to 52 minutes in patients with chronic obstructive pulmonary disorder (COPD) who have insomnia while preserving oxygen saturation (SaO2) ...
Discusses a number of issues relating to the pharmacotherapy of depression in elderly people. The similarities and differences between various antidepressant medications; Dose and length of treatment; Management of the patient not responding to first-line treatment; The need for long-term collaboration ...
The high prevalence of COPD together with its high level of misdiagnosis and late diagnosis dictate the necessity for the development and implementation of clinical practice guidelines (CPGs) in order to improve the management of this disease. High-quality, evidence-based international ...